Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

DN-108

Product Specifications

CAS Number

195604-21-8

Target

PPAR

Related Pathways

DNA Damage/DNA Repair, Metabolism

Bioactivity

DN-108, a thiazolidinedione derivative, acts as an orally active peroxisome proliferator-activated receptor γ (PPARγ) agonist with antidiabetic properties. It improves hyperglycemia, hypertriglyceridemia, and hyperinsulinemia in diabetic mouse models. DN-108 enhances tissue glucose uptake (e.g., increases 2-deoxyglucose uptake in L6 muscle cells) and inhibits fatty acid synthase activity, making it a promising candidate for type 2 diabetes research.

Smiles

O=C1SC(C(=O)N1)CC2=CC=C(C=C2)NC(=O)C3(C=4C=CC=CC4)CC3

Molecular Formula

C20H18N2O3S

Molecular Weight

366.43

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Brentuximab Biosimilar - Research Grade
MBS3030498-01 1 mg

Brentuximab Biosimilar - Research Grade

Sign In for Pricing
View Details
Brentuximab Biosimilar - Research Grade
MBS3030498-02 5 mg

Brentuximab Biosimilar - Research Grade

Sign In for Pricing
View Details
Brentuximab Biosimilar - Research Grade
MBS3030498-03 10 mg

Brentuximab Biosimilar - Research Grade

Sign In for Pricing
View Details
Brentuximab Biosimilar - Research Grade
MBS3030498-04 20 mg

Brentuximab Biosimilar - Research Grade

Sign In for Pricing
View Details
Brentuximab Biosimilar - Research Grade
MBS3030498-05 50 mg

Brentuximab Biosimilar - Research Grade

Sign In for Pricing
View Details
Brentuximab Biosimilar - Research Grade
MBS3030498-06 100 mg

Brentuximab Biosimilar - Research Grade

Sign In for Pricing
View Details